Patients with a positive anti-MDA5 antibody (anti-MDA5 Ab+) are typically characterized by the presence of skin ulcer and rapidly progressive interstitial lung disease (RP-ILD), whereas the manifestations of myositis are frequently slight or absent (3, 4). Here, IFIH1 is linked to Skin ulcer.